WEKO3
アイテム
{"_buckets": {"deposit": "c8d48a64-1658-4f69-b7e2-55a434dfb98e"}, "_deposit": {"created_by": 1, "id": "45887", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "45887"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00045887", "sets": ["1"]}, "author_link": ["456447", "456437", "456433", "456449", "456451", "456438", "456444", "456432", "456441", "456434", "456439", "456440", "456443", "456436", "456448", "456450", "456446", "456435", "456442", "456445"], "item_8_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2010-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "190", "bibliographicPageStart": "184", "bibliographicVolumeNumber": "15", "bibliographic_titles": [{"bibliographic_title": "International Journal of Clinical Oncology"}]}]}, "item_8_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "OBJECTIVES: The objectives of this study were to reveal the utility of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) within 7 days after chemoradiotherapy to predict prognosis in patients with postoperative recurrent esophageal cancer. MATERIALS AND METHODS: Patients scheduled to undergo concurrent chemoradiotherapy for postoperative locoregional recurrence of esophageal cancer were recruited. Selection criteria were: (1) locoregional recurrence, (2) no previous radiation therapy, (3) planning treatment with concurrent chemoradiotherapy, (4) FDG-PET performed \u003c2 weeks before chemoradiotherapy, and (5) no serious diabetes. FDG-PET was performed \u003c7 days after chemoradiotherapy. No more treatment after chemoradiotherapy was given until disease progression was diagnosed according to the Response Evaluation Criteria in Solid Tumors (RECIST). Correlations of FDG-PET findings with cause-specific survival and local control rates were investigated prospectively. RESULTS: Twenty patients were enrolled. Median observation period of patients who survived was 45.0 months. Median maximum standardized uptake value (SUV(max)) after chemoradiotherapy was 2.4, and median SUV(max) before chemoradiotherapy was 8.4. Cause-specific survival and local control rates were significantly better for patients with SUV(max) \u003c or = 2.4 after chemoradiotherapy (log-rank test, P = 0.033 and 0.010, respectively). SUV(max) before chemoradiotherapy tended to be correlated only with cause-specific survival rate (log-rank test, P = 0.076). Change in metabolic activity of FDG was significantly correlated with local control rate (log-rank test, P = 0.042). CONCLUSIONS: FDG-PET performed even \u003c7 days after chemoradiotherapy predicts prognosis in patients with postoperative recurrent esophageal cancer.", "subitem_description_type": "Abstract"}]}, "item_8_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1341-9625", "subitem_source_identifier_type": "ISSN"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Jingu, Keiichi"}], "nameIdentifiers": [{"nameIdentifier": "456432", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kaneta, Tomohiro"}], "nameIdentifiers": [{"nameIdentifier": "456433", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nemoto, Kenji"}], "nameIdentifiers": [{"nameIdentifier": "456434", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takeda, Ken"}], "nameIdentifiers": [{"nameIdentifier": "456435", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ogawa, Yoshihiro"}], "nameIdentifiers": [{"nameIdentifier": "456436", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ariga, Hisanori"}], "nameIdentifiers": [{"nameIdentifier": "456437", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Koto, Masashi"}], "nameIdentifiers": [{"nameIdentifier": "456438", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sakayauchi, Toru"}], "nameIdentifiers": [{"nameIdentifier": "456439", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takai, Yoshihiro"}], "nameIdentifiers": [{"nameIdentifier": "456440", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takahashi, Shoki"}], "nameIdentifiers": [{"nameIdentifier": "456441", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yamada, Syougo"}], "nameIdentifiers": [{"nameIdentifier": "456442", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "神宮 啓一", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456443", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "根本 建二", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456444", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "武田 賢", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456445", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小川 芳弘", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456446", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "有賀 久哲", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456447", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小藤 昌志", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456448", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "坂谷内 徹", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456449", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "高井 良尋", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456450", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "山田 章吾", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "456451", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer."}]}, "item_type_id": "8", "owner": "1", "path": ["1"], "permalink_uri": "https://repo.qst.go.jp/records/45887", "pubdate": {"attribute_name": "公開日", "attribute_value": "2010-09-06"}, "publish_date": "2010-09-06", "publish_status": "0", "recid": "45887", "relation": {}, "relation_version_is_last": true, "title": ["18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer."], "weko_shared_id": -1}
18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer.
https://repo.qst.go.jp/records/45887
https://repo.qst.go.jp/records/458872b51ce85-724b-45dd-a149-0b02e352d8bc
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2010-09-06 | |||||
タイトル | ||||||
タイトル | 18F-fluorodeoxyglucose positron emission tomography immediately after chemoradiotherapy predicts prognosis in patients with locoregional postoperative recurrent esophageal cancer. | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
Jingu, Keiichi
× Jingu, Keiichi× Kaneta, Tomohiro× Nemoto, Kenji× Takeda, Ken× Ogawa, Yoshihiro× Ariga, Hisanori× Koto, Masashi× Sakayauchi, Toru× Takai, Yoshihiro× Takahashi, Shoki× Yamada, Syougo× 神宮 啓一× 根本 建二× 武田 賢× 小川 芳弘× 有賀 久哲× 小藤 昌志× 坂谷内 徹× 高井 良尋× 山田 章吾 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | OBJECTIVES: The objectives of this study were to reveal the utility of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) within 7 days after chemoradiotherapy to predict prognosis in patients with postoperative recurrent esophageal cancer. MATERIALS AND METHODS: Patients scheduled to undergo concurrent chemoradiotherapy for postoperative locoregional recurrence of esophageal cancer were recruited. Selection criteria were: (1) locoregional recurrence, (2) no previous radiation therapy, (3) planning treatment with concurrent chemoradiotherapy, (4) FDG-PET performed <2 weeks before chemoradiotherapy, and (5) no serious diabetes. FDG-PET was performed <7 days after chemoradiotherapy. No more treatment after chemoradiotherapy was given until disease progression was diagnosed according to the Response Evaluation Criteria in Solid Tumors (RECIST). Correlations of FDG-PET findings with cause-specific survival and local control rates were investigated prospectively. RESULTS: Twenty patients were enrolled. Median observation period of patients who survived was 45.0 months. Median maximum standardized uptake value (SUV(max)) after chemoradiotherapy was 2.4, and median SUV(max) before chemoradiotherapy was 8.4. Cause-specific survival and local control rates were significantly better for patients with SUV(max) < or = 2.4 after chemoradiotherapy (log-rank test, P = 0.033 and 0.010, respectively). SUV(max) before chemoradiotherapy tended to be correlated only with cause-specific survival rate (log-rank test, P = 0.076). Change in metabolic activity of FDG was significantly correlated with local control rate (log-rank test, P = 0.042). CONCLUSIONS: FDG-PET performed even <7 days after chemoradiotherapy predicts prognosis in patients with postoperative recurrent esophageal cancer. | |||||
書誌情報 |
International Journal of Clinical Oncology 巻 15, 号 2, p. 184-190, 発行日 2010-04 |
|||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1341-9625 |